About Us | National Core Facility for Biopharmaceuticals

Mission

National Core Facility for Biopharmaceuticals (NCFB) is aimed to make efficient use of the established research resources and provide professional high-tech service and expert consultation to academic and industrial PIs in Taiwan.

NCFB integrates Core Facility Program for Biotechnology and Pharmaceuticals, Resource Centers developed during the National Research Program for Biopharmaceuticals, the National Core Facility Program for Biotechnology, and R & D teams with prescient technology in Taiwan into a new platform. Taking the advantage of established experiences, this platform goes on developing cutting-edge technologies and provides professional high-tech service and expert consultation. To fulfill the needs of academic and industrial PIs, regular users’ committee and annul review is scheduled.

NCFB not only offers an excellent environment for the development of precision medicine, biotechnology and pharmaceutical research, but also enhances the transition from basic research to clinical trial.

Core Facility

Organizational Chart

Core Facility

5th National Core Facility for Biopharmaceuticals (2023/5/1~2027/4/30)

Microbiota

M1
Establishment of research collaboration and technical service for national human microbiome core facilities

Next Generation Medicine

Bioresources

Gene platform

Bioinformatics

BSL-3 Laboratories

Animal Model

Imaging and Structure Analysis

Human Resources

4th National Core Facility for Biopharmaceuticals (2019/05/01~2023/04/30)

C1
Genomics Center for Clinical and Biotechnological Applications
C2
National Center for Genome Medicine
TR6
Pharmacogenomics Lab
C6
RNA Technology Platform and Gene Manipulation Core

Bioinformatics

E2
Bioinformatics Core Facility for Biotechnology and Pharmaceuticals
GP1
National Biomedical Data Service and Analysis Computing Platform

Animal Models

A4
Transgenic mouse models core facility
A12
Taiwan Mouse Clinic and Animal Consortium--National Comprehensive Mouse Phenotyping and Drug Testing Center
A9
Taiwan Zebrafish Technology and Resources

Image and Structure Analysis

D4
The Synchrotron Radiation Protein Crystallography Core Facility
A10
The Bio-image Core
A13
Translational biomedical imaging platform
A14
International Institute for Macromolecular Analysis and Nanomedicine Innovation-i, MANI

Bioresource

iPSC
Human Disease Induced Pluripotent Stem Cells Service Consortium
SB2
The establishment of a clinico-pathological network and databaseon hepatocellular carcinoma in Taiwan and Taiwan lung cancer tissue/specimen and information resource center
NPS
Natural Product Libraries and High-Throughput Screening Core
FCT
Resource center for Drosophila as a biomedical research model
CECF
Elevating Taiwan C. elegans core facility and service towards a National Core Facility for Biopharmaceuticals
TYBC
Taiwan Yeast Bio-Resources Center

BLS-3 Laboratories

P3-1
Biosafety level 3 core laboratory
P3-2
Emerging Infectious Diseases Core Facility Platform
P3-3
BSL3 Research and Analysis Laboratory

3rd National Core Facility Program for Biotechnology（2017/05/01~2019/04/30）

A4
Transgenic Mouse Core Facility
A11
Humanized Mouse Platform: Patient Derived Tumor, Gut Microbiota Transplantation And Gene Modification Service
A12
Taiwan Animal Consortium-National Phenotyping and Drug Testing Center
A9
Zebrafish platforms for disease and toxicity test
A10
Bioimaging Core Facility
C1
Genomics Center for Clinical and Biotechnological Applications
C2
National Center for Genome Medicine
C5/TR6
Pharmacogenomics Core Laboratory
C6
RNAi core facility
E2
Bioinformatics Core Facility for Biotechnology and Pharmaceuticals
GP1
National Biomedical Data Service and Analysis Computing Platform
D4
Synchrotron Protein Crystallography Facility
SB2
The establishment of a clinico-pathological network and database on hepatocellular carcinoma in Taiwan and Taiwan lung cancer tissue/specimen and information resource center
iPSC
Human Disease iPS Cell Service Consortium